Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

GNRHR anticorps (AA 1-29)

GNRHR Reactivité: Humain, Rat, Lapin IF, FACS, IHC (p) Hôte: Souris Monoclonal F1G4 or GNRH03 unconjugated
N° du produit ABIN3026049
  • Antigène Voir toutes GNRHR Anticorps
    GNRHR (Gonadotropin-Releasing Hormone Receptor (GNRHR))
    Épitope
    • 29
    • 25
    • 8
    • 5
    • 3
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    AA 1-29
    Reactivité
    • 61
    • 14
    • 13
    • 1
    • 1
    Humain, Rat, Lapin
    Hôte
    • 35
    • 27
    • 1
    Souris
    Clonalité
    • 35
    • 28
    Monoclonal
    Conjugué
    • 32
    • 5
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    Cet anticorp GNRHR est non-conjugé
    Application
    • 28
    • 27
    • 25
    • 24
    • 9
    • 8
    • 6
    • 4
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    Immunofluorescence (IF), Flow Cytometry (FACS), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p))
    Purification
    Protein G affinity chromatography
    Immunogène
    A synthetic peptide aa 1-29 (MANSASPEQNQHCSAINNSIPLMQGNLPY) from the N-terminal of human GnRHR was used as the immunogen for the GnRH Receptor antibody.
    Clone
    F1G4 or GNRH03
    Isotype
    IgG1 kappa
    Top Product
    Discover our top product GNRHR Anticorps primaire
  • Indications d'application
    Optimal dilution of the GnRH Receptor antibody should be determined by the researcher.

    1. Staining of formalin-fixed tissues requires boiling tissue sections in 10  mM Tris with 1  mM EDTA,  pH 9.0, for 10-20 min followed by cooling at RT for 20 min
    2. The prediluted format is supplied in a dropper bottle and is optimized for use in IHC. After epitope retrieval step (if required), drip mAb solution onto the tissue section and incubate at RT for 30 min.\. Flow Cytometry: 0.5-1 μg/million cells in 0.1ml,Immunofluorescence: 1-2 μg/mL,Immunohistochemistry (FFPE): 1-2 μg/mL for 30 min at RT (1),Prediluted format : incubate for 30 min at RT (2)

    Restrictions
    For Research Use only
  • Concentration
    1 mg/mL
    Buffer
    1 mg/mL in 1X PBS, BSA free, sodium azide free
    Agent conservateur
    Azide free
    Stock
    4 °C,-20 °C
    Stockage commentaire
    Store the GnRH Receptor antibody at 2-8°C (with azide) or aliquot and store at -20°C or colder (without azide).
  • Antigène
    GNRHR (Gonadotropin-Releasing Hormone Receptor (GNRHR))
    Autre désignation
    GnRH Receptor (GNRHR Produits)
    Synonymes
    anticorps GNRHR1, anticorps GRHR, anticorps HH7, anticorps LHRHR, anticorps LRHR, anticorps GNRHR, anticorps GH1, anticorps Lhrhr, anticorps GNRHR1/III, anticorps GNRHR2, anticorps xgnrhr, anticorps gnrhr3/ii, anticorps gnrh-r, anticorps gonadotropin releasing hormone receptor, anticorps gonadotropin-releasing hormone receptor, anticorps GNRHR, anticorps Gnrhr, anticorps gnrhr, anticorps gnrh-r
    Sujet
    Recognizes an epitope on the extracellular domain of gonadotropin releasing hormone (GnRH) receptor or luteinizing hormone receptor (LHCGR). Lutropin (also designated luteinizing hormone) plays a role in spermatogenesis and ovulation by stimulating the testes and ovaries to produce steroids. Gonadotropin (also designated choriogonadotropin) production in the placenta maintains estrogen and progesterone levels during the first trimester of pregnancy. Ovaries and testes abundantly express luteinizing hormone/choriogonadotropin receptor. GnRH receptor contains seven hydrophobic transmembrane domains connected by hydrophilic extracellular and intracellular loops characteristic of G-protein coupled receptors. GnRH stimulates the gonadotrophs of the anterior pituitary to secrete luteinizing hormone (LH) as well as follicle-stimulating hormone (FSH). GnRH influences the protective effect of pregnancy and Gonadotropin against breast cancer. The expression of GnRH on breast carcinoma correlates in part to the degree of tumor differentiation. GnRH-positive breast tumors occur more frequently in tumors with greater cell differentiation in premenopausal women. GnRH is present in luteal and granulosa cells as well as in ovarian cell membrane preparations.
Vous êtes ici:
Support technique